TITLE

Community perceptions of malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combination therapy

AUTHOR(S)
Asante, Kwaku P.; Abokyi, Livesy; Zandoh, Charles; Owusu, Ruth; Awini, Elizabeth; Sulemana, Abubakari; Amenga-Etego, Seeba; Adda, Robert; Boahen, Owusu; Segbaya, Sylvester; Mahama, Emmanuel; Bart-Plange, Constance; Chandramohan, Daniel; Owusu-Agyei, Seth
PUB. DATE
January 2010
SOURCE
BMC Public Health;2010, Vol. 10 Issue 1, p409
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Artesunate-amodiaquine (AS-AQ) was introduced in Ghana as the first line drug for treatment of uncomplicated malaria in 2004. We report the perceptions of malaria and malaria treatment behaviour, the community awareness of and perceptions about AS-AQ two years after the introduction of this ACT treatment for malaria. Methods: Two surveys were conducted; a cross-sectional survey of 729 randomly selected household heads (urban-362, rural-367) and 282 women with children < 5 years (urban-121, rural-161) was conducted in 2006. A district wide survey was conducted in 2007 to assess awareness of AS-AQ. These were complemented with twenty-eight focus group discussions (FGDs) and 16 key informant interviews (KII) among community members and major stakeholders in the health care delivery services. All nine (9) health facilities and five (5) purposively selected drug stores were audited in order to identify commonly used anti-malarials in the study area at the time of the survey. Results: Majority of respondents ( > 75%) in the sampled survey mentioned mosquito bites as the cause of malaria. Other causes mentioned include environmental factors (e.g. dirty surroundings) and standing in the sun. Close to 60% of the household heads and 40% of the care-givers interviewed did not know about AS-AQ. The community respondents who knew about and had ever taken AS-AQ perceived it to be a good drug; although they mentioned they had experienced some side effects including headaches and body weakness. Co-blistered AS-AQ was available in all the government health facilities in the study area. Different formulations of ACTs were however found in urban chemical shops but not in rural chemical stores where monotherapy antimalarials were predominant. Conclusion: The knowledge of fever as a symptom of malaria is high among the study population. The awareness of AS-AQ therapy and its side-effect was low in the study area. Community education and sensitization, targeting all categories of the population, has to be intensified to ensure an efficient implementation process.
ACCESSION #
52840536

 

Related Articles

  • Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Achan, Jane; Talisuna, Ambrose O.; Erhart, Annette; Yeka, Adoke; Tibenderana, James K.; Baliraine, Frederick N.; Rosenthal, Philip J.; D'Alessandro, Umberto // Malaria Journal;2011 Supplement 1, Vol. 10 Issue Suppl 1, p144 

    Quinine remains an important anti-malarial drug almost 400 years after its effectiveness was first documented. However, its continued use is challenged by its poor tolerability, poor compliance with complex dosing regimens, and the availability of more efficacious anti-malarial drugs. This...

  • Evidence Update.  // Africa Health;Sep2011, Vol. 33 Issue 6, p32 

    The article discusses the findings of a study regarding the efficacy of using artesunate, an antimalaria derived from artemisinin, instead of quinine for treating severe malaria. It provides an overview of the disease and the role of artesunate in the treatment of the disease. It mentions the...

  • New Perspectives for Adjuvant Therapy in Severe Malaria. Prato, Mauro; Giribaldi, Giuliana // Journal of Bacteriology & Parasitology;2012, Vol. 3 Issue 5, p1 

    The authors reflect on the importance of developing fast acting drugs to treat severe malaria. They offer information on malaria which is a common parasitic disease that leads to an estimated of one million deaths annually that mainly affects young children. They discuss the treatment for...

  • Advances in the Treatment of Malaria. Castelli, Francesco; Tomasoni, Lina Rachele; Matteelli, Alberto // Mediterranean Journal of Hematology & Infectious Diseases;2012, Vol. 4 Issue 1, p1 

    Malaria still claims a heavy toll of deaths and disabilities even at the beginning of the third millennium. The inappropriate sequential use of drug monotherapy in the past has facilitated the spread of drug-resistant P falciparum, and to a lesser extend P vivax, strains in most of the malaria...

  • Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola. Lussiana, Cristina; Floridia, Marco; do Rosário, Joana Martinho; Fortes, Filomeno; Allan, Richard // Transactions of the Royal Society of Tropical Medicine & Hygiene;Dec2016, Vol. 110 Issue 10, p588 

    Background: Artemisinin-based combination therapies (ACTs) against malaria are subsidized in many African countries, but the impact of subsidy programs in reducing the sales of concomitantly available antimalarial monotherapies is poorly defined. Methods: Data from The MENTOR initiative, that...

  • Manual blood exchange transfusion does not significantly contribute to parasite clearance in artesunate-treated individuals with imported severe Plasmodium falciparum malaria. Kreeftmeijer-Vegter, Annemarie R.; Melo, Mariana de Mendonça; de Vries, Peter J.; Koelewijn, Rob; van Hellemond, Jaap J.; van Genderen, Perry J. J. // Malaria Journal;2013, Vol. 12 Issue 1, Special section p1 

    Background: Exchange transfusion (ET) has remained a controversial adjunct therapy for the treatment of severe malaria. In order to assess the relative contribution of ET to parasite clearance in severe malaria, all patients receiving ET as an adjunct treatment to parenteral quinine or to...

  • Comparison of artesunate and quinine in the treatment of Sudanese children with severe Plasmodium falciparum malaria. Eltahir, Hatim G.; Omer, Abubaker A.; Mohamed, Ayoub A.; Adam, Ishag // Transactions of the Royal Society of Tropical Medicine & Hygiene;Oct2010, Vol. 104 Issue 10, p684 

    Summary: Sixty-six children presenting to Singa hospital, Sudan with different manifestations of severe Plasmodium falciparum malaria were randomly divided into two well-matched groups (33 in each arm) to receive either intravenous artesunate 2·4mg/kg at 0, 12, and 24hours, then daily, or...

  • Artemisinin derivatives versus quinine for cerebral malaria in African children: a systematic review. Kyu, Hmwe Hmwe; Fernández, Eduardo // Bulletin of the World Health Organization;Dec2009, Vol. 87 Issue 12, p896 

    Objective To summarize the existing evidence on the efficacy of artemether and arteether, two artemisinin derivatives, versus quinine for treating cerebral malaria in children. Methods We searched the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE and the...

  • A randomized trial of the efficacy of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital, Cameroon. Maka, Daniel Ethe; Chiabi, Andreas; Ndikum, Valentine; Achu, Dorothy; Mah, Evelyn; Nguefack, Séraphin; Nana, Pamela; Njoumemi, Zakariaou; Mbacham, Wilfred; Mbonda, Elie // Malaria Journal;10/31/2015, Vol. 14 Issue 1, p1 

    Background: Severe malaria is a medical emergency with high mortality in children below 5 years of age especially in sub-Saharan Africa. Recently, quinine has been replaced by artesunate as the first-line drug in the treatment of severe malaria in Cameroon. No local data are yet available on the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics